From: The clinical use of biomarkers as prognostic factors in Ewing sarcoma
Author | Year | Pt number | P |
---|---|---|---|
Aparicio et al, Oncology 55, 20-6[9] | 1998 | 116 | 0.0016 |
Kawai et al, Cancer 82, 851-9[22] | 1998 | 20 | 0.0038 |
Ahmad et al, Cancer 85, 725-31[23] | 1999 | 24 | 0.277 |
Givens et al Int J Oncol 14 (6), 1039-43[12] | 1999 | 85 | NS |
Cotterill et al, J Clin Oncol 18, 3108-14[24] | 2000 | 975 | 0.001 |
De Alava et al, Cancer 89, 783-92[25] | 2000 | 55 | 0.02 |
Jenkin et al, Med Pediatr Oncol 37, 383-9[14] | 2001 | 93 | 0.0001 |
Oberlin et al, B J Cancer 85 (11), 1646-54[26] | 2001 | 141 | 0.002 |
Rutkowski et al, J Surg Oncol 84, 151-9[27] | 2003 | 13 | 0.05 |
Krasin et al, Pediatr Blood Cancer 43, 229-36[28] | 2004 | 37 | S |
Matsunobu et al, Clin Cancer Res 10, 1003-12[29] | 2004 | 21 | 0.05 |
Krasin et al, Cancer 104, 367-73[28] | 2005 | 33 | 0.25 |
Aksnes et al, Acta Oncol 45, 38-46[30] | 2006 | 56 | 0.001 |
Bacci et al, Acta Oncol 45, 469-75[16] | 2006 | 579 | 0.0004 |
Mikulic et al, J Pediatr Surg 41, 524-9[31] | 2006 | 27 | 0.031 |
Cheung et al, Clin Cancer Res 13 (23), 6978-83[32] | 2007 | 28 | NS |
Rodriguez-Galindo et al, Ann Oncol 19, 814-20[33] | 2008 | 220 | 0.018 |
Yonemori et al, J Cancer Res Clin Oncol 134, 389-95[34] | 2008 | 79 | S |
Jawad et al, Cancer 115, 3526-36[19] | 2009 | 1631 | 0.001 |
Kikuta et al, Clin Cancer Res 15 (8), 2885-94[20] | 2009 | 8 | 0.018 |
Lee et al, Cancer 116, 1964-73[35] | 2010 | 725 | 0.001 |
Xie et al, Chin J Cancer 29 (4), 420-4 | 2010 | 18 | 0.44 |